Arexis develops pharmaceuticals for the treatment of metabolic and inflammatory diseases, e. g. lipid malabsorption, diabetes, atopic dermatitis (inflammatory skin disease) and rheumatoid arthritis.

Year exited: 2005

By continuing to interact with the site, you agree to the use of cookies. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.